- Study: Participation in diabetes education associated with greater ability to self-manage
- Novo Nordisk launches new insulin device
- Mylan launches generic version of Prandin
- Study pinpoints protective genetic mutations for Type 2 diabetes
- Diabetics constantly on the look-out for new ways to manage disease
HOUSTON — Novo Nordisk is starting an organization in Houston designed to provide assistance to local diabetes education programs, the Danish drug maker said Tuesday.
The company announced that it was accepting applications from local organizations for funding from Novo Nordisk Community Care Houston, one of more than 20 Novo Nordisk Community Care programs started in 2011 that provide funding to local groups. The drug maker is investing $80,000 on the Houston initiative.
"More than 3.2 million Texans were faced with diabetes in 2010," Novo Nordisk executive director of communications and public affairs Lori Moore said. "As an industry leader, Novo Nordisk is committed to reversing the trend of the diabetes crisis. We recognize that community-based organizations play a critical role in providing diabetes education and care that can help defeat this disease."
Novo Nordisk has created similar programs in such cities as Boston, Philadelphia, Atlanta and Minneapolis, awarding $415,000 to diabetes programs.